BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND B2M, P61769, 567, ENSG00000166710
194 results:

  • 1. CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
    Okuno K; Ikemura K; Okamoto R; Oki K; Watanabe A; Kuroda Y; Kidachi M; Fujino S; Nie Y; Higuchi T; Chuman M; Washio M; Sakuraya M; Niihara M; Kumagai K; Sangai T; Kumamoto Y; Naitoh T; Hiki N; Yamashita K
    PLoS One; 2024; 19(4):e0299827. PubMed ID: 38557819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between polyunsaturated fatty acids in adipose tissue and mortality of colorectal cancer patients.
    Roux-Levy C; Binquet C; Vaysse C; Scherrer ML; Ayav A; Ortega-Deballon P; Lakkis Z; Liu D; Deguelte S; Cottet V
    Nutrition; 2024 May; 121():112358. PubMed ID: 38401197
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Potential Molecular Markers Related to Lymph Node Metastasis and Stalk Resection Margins in Pedunculated T1 colorectal cancers Using Digital Spatial Profiling: A Pilot Study with a Small Case Series.
    Kwon MJ; Park HY; Lim H; Son IT; Kim MJ; Kim NY; Kim MJ; Nam ES; Cho SJ; Bang WJ; Kang HS
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256174
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nine dietary habits and risk of colorectal cancer: a Mendelian randomization study.
    He M; Huan L; Wang X; Fan Y; Huang J
    BMC Med Genomics; 2024 Jan; 17(1):21. PubMed ID: 38233852
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Next-generation Multi-target Stool DNA Panel Accurately Detects colorectal cancer and Advanced Precancerous Lesions.
    Gagrat ZD; Krockenberger M; Bhattacharya A; Gagrat BZ; Leduc CM; Matter MB; Fourrier KD; Mahoney DW; Edwards V DK; Lidgard GP; Limburg PJ; Johnson SC; Domanico MJ; Kisiel JB
    Cancer Prev Res (Phila); 2024 Mar; 17(3):119-126. PubMed ID: 38224564
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MLH1 Promotor Hypermethylation in colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.
    Helderman NC; Andini KD; van Leerdam ME; van Hest LP; Hoekman DR; Ahadova A; Bajwa-Ten Broeke SW; Bosse T; van der Logt EMJ; Imhann F; Kloor M; Langers AMJ; Smit VTHBM; Terlouw D; van Wezel T; Morreau H; Nielsen M
    J Mol Diagn; 2024 Feb; 26(2):106-114. PubMed ID: 38061582
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Screening and validation of the optimal panel of reference genes in colonic epithelium and relative cancer cell lines.
    Hu Y; Jiang Q; Zhai X; Liu L; Hong Y
    Sci Rep; 2023 Oct; 13(1):17777. PubMed ID: 37853035
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk of delayed bleeding after colorectal endoscopic submucosal dissection: the Limoges Bleeding Score.
    Albouys J; Montori Pina S; Boukechiche S; Albéniz E; Vidal G; Legros R; Dahan M; Lepetit H; Pioche M; Schaefer M; Geyl S; Carrier P; Loustaud-Ratti V; Valgueblasse V; Brule C; Rodrigues R; Enguita German M; Jacques J
    Endoscopy; 2024 Feb; 56(2):110-118. PubMed ID: 37816392
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study.
    Guzmán-Gallego EA; Arias-Ortiz NE; Rodríguez-Betancourt JD
    Rev Bras Epidemiol; 2023; 26():e230040. PubMed ID: 37729347
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The optimal surgery timing after stenting in colorectal cancer patients with malignant obstruction: additionally compared with emergency surgery.
    Na JE; Kim ER; Kim JE; Hong SN; Kim YH; Chang DK
    World J Surg Oncol; 2023 Aug; 21(1):259. PubMed ID: 37612670
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immune Marker Spatial Distribution and Clinical Outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced colorectal Carcinomas.
    Saberzadeh-Ardestani B; Graham RP; McMahon S; Ahanonu E; Shi Q; Williams C; Hubbard A; Zhang W; Muranyi A; Yan D; Jin Z; Shanmugam K; Sinicrope FA
    Clin Cancer Res; 2023 Oct; 29(20):4268-4277. PubMed ID: 37566222
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. YWHAZ and TBP are potential reference gene candidates for qPCR analysis of response to radiation therapy in colorectal cancer.
    Kim S; Park JY; Lee HW; Bae SU; Kim KE; Byun SJ; Seo I
    Sci Rep; 2023 Aug; 13(1):12902. PubMed ID: 37558778
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Feasibility of high-resolution readout-segmented echo-planar imaging with simultaneous multislice imaging in assessing rectal cancer.
    Huang H; Zhou M; Gong T; Wang Y
    Abdom Radiol (NY); 2023 Jul; 48(7):2258-2269. PubMed ID: 37142823
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Optimizing Screening for colorectal cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden.
    Petersen MM; Kleif J; Jørgensen LN; Hendel JW; Seidelin JB; Madsen MR; Vilandt J; Brandsborg S; Rasmussen JS; Andersen LM; Khalid A; Ferm L; Gawel SH; Martens F; Andersen B; Rasmussen M; Davis GJ; Christensen IJ; Therkildsen C
    Clin Colorectal Cancer; 2023 Jun; 22(2):199-210. PubMed ID: 36878807
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Global productivity and research trends of colorectal carcinoma: A scientometric analysis of studies published between 1980 and 2021.
    Şahiner İT; Altunal Ç
    Medicine (Baltimore); 2023 Feb; 102(8):e33037. PubMed ID: 36827037
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer.
    Grosgeorges M; Picque Lasorsa L; Pastor B; Prévostel C; Crapez E; Sanchez C; Frayssinoux F; Jarlier M; Pezzella V; Monard L; Ychou M; Thierry AR; Mazard T; Blache P
    Sci Rep; 2023 Feb; 13(1):2739. PubMed ID: 36792801
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR cancers.
    Liu F; Zhong F; Wu H; Che K; Shi J; Wu N; Fu Y; Wang Y; Hu J; Qian X; Fan X; Wang W; Wei J
    Oncologist; 2023 Mar; 28(3):e136-e144. PubMed ID: 36724040
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
    de Vries NL; van de Haar J; Veninga V; Chalabi M; Ijsselsteijn ME; van der Ploeg M; van den Bulk J; Ruano D; van den Berg JG; Haanen JB; Zeverijn LJ; Geurts BS; de Wit GF; Battaglia TW; Gelderblom H; Verheul HMW; Schumacher TN; Wessels LFA; Koning F; de Miranda NFCC; Voest EE
    Nature; 2023 Jan; 613(7945):743-750. PubMed ID: 36631610
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient colorectal cancer Cohort Treated with Immunotherapy.
    Élez E; Mulet-Margalef N; Sanso M; Ruiz-Pace F; Mancuso FM; Comas R; Ros J; Argilés G; Martini G; Sanz-Garcia E; Baraibar I; Salvà F; Noguerido A; Cuadra-Urteaga JL; Fasani R; Garcia A; Jimenez J; Aguilar S; Landolfi S; Hernández-Losa J; Braña I; Nuciforo P; Dienstmann R; Tabernero J; Salazar R; Vivancos A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613564
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.